-
FDA Approves Hovilpri for Refractory HSV Lesions - Specialty Pharmacy Continuum
... disease service at Memorial Sloan Kettering Cancer Center and a ... Huntington's Disease · Clinical. SEPTEMBER 8, 2026. Deutetrabenazine ...Read more
-
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and ...
D., Chief Executive Officer of Arexera. "Huntington's disease is predominantly a disease of the deep brain, has well-established genetic drivers and a ...Read more
-
uniQure assumed with a Buy at UBS - TipRanks.com
The company's AMT-130 may be the first disease-modifying therapy approved for Huntington's disease, with the BLA having been submitted in early ...Read more
-
Gene and Cell Therapies Targeting CNS Disorders Market - openPR.com
In 2025, the United States had approximately 30,000 cases of amyotrophic lateral sclerosis (ALS) and 25,000 diagnosed prevalent cases of Huntington's ...Read more
-
Jennifer Lynne Barretta Obituary (2026) - Elkhart, IN - Stemm Lawson Peterson Funeral ...
... Huntington's Disease Society of America (HDSA) which supports families affected by Huntington's and funds research towards finding a cure.Read more
-
Support Team Hope - The SandPaper
... Huntington's disease (a disease that's like having ALS, Parkinson's disease and Alzheimer's disease at the same time). There is no cure at this ...Read more
-
Cornell scientists identify rare human genetic disorder in two unusually long-legged cats
Jan. 16, 2025 — Scientists have discovered a surprising mechanism by which the inherited genetic mutation known to cause Huntington's disease leads to ...Read more
-
CHDI Report: Day 2 - HDBuzz
a protein found in the brain regions damaged early in Huntington's disease. ... Huntington's disease research news. In plain language. Written by ...Read more
-
การตรวจทางพันธุกรรมโรคฮันติงตัน: ทำความเข้าใจจำนวน CAG - Kantesti
A Huntington disease genetic test measures CAG repeats in HTT: 26 or fewer is normal, 27–35 intermediate, 36–39 reduced penetrance, and 40 or more ...Read more
-
What a baby's gene therapy owes to curiosity-driven research - KevinMD.com
Some research starts with an obvious destination: a disease to treat, a test to build, a technology to improve. Other research begins much earlier ...Read more
-
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and ...
... Huntington's disease franchise and broader neurological disease pipeline focused on genetically validated drivers of disease –. - ATL-101 ...Read more
-
Care home in Castleford achieves national end-of-life care accreditation - Wakefield Express
The Exemplar Health Care home provides nurse-led care for adults with complex health needs, including advanced Huntington's disease and dementia.Read more
-
Arrowhead's brain-targeting drug lowers Alzheimer's tau protein in early study
It also has a partnership with Novartis centered on Parkinson's disease and another with Sarepta Therapeutics covering Huntington's disease. Tau ...Read more
-
Intermittent fasting may slow Huntington's progression - study - NR Times
Huntington's is an inherited neurological disorder that progressively damages nerve cells involved in movement, thinking and emotional regulation.Read more
-
Garrett Motion to Hold Third Quarter 2026 Financial Results Conference Call on Thursday ...
... Huntington's Disease Franchise · Macerich Schedules Third Quarter 2026 Earnings Release and Conference Call · Yukon Metals Confirms New Copper-Gold ...Read more
GoogleNews Aggregator
HDinHD > GoogleNews Aggregator
